Molecular marker for distinguishing papillary thyroid carcinoma from benign thyroid nodules
A papillary carcinoma and molecular marker technology, which is applied in the field of molecular markers and detection kits for distinguishing papillary thyroid carcinoma and benign thyroid nodules, and can solve problems such as the decreased expression level of LncRNAGAS8-AS1
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1. Detection of RNA sequence fragments of GAS8-AS1 in the target population
[0026] 1. Take whole blood from the patient on an empty stomach, and centrifuge to obtain 2ml of plasma;
[0027] 2. Use TRIZOL (Invitrogen life technologies) method to extract total RNA in plasma;
[0028] 3. Through SuperScriptTM III Reverse Transcriptase (Invitrogen) and 2.5mM dNTP mixture (dATP, dGTP, dCTP and dTTP each 2.5mM) (HyTest Ltd) Primer (Yingjun Biotechnology Co., Ltd.) in Gene Amp PCR System 9700 (AppliedBiosystems) Reverse transcription reaction was carried out to obtain cDNA;
[0029] 4. Using 2X PCR master mix (Arraystar) kit, prepare the following reaction system: 2×MasterMix 5μl, 10uM primer F 0.5μl, heteroprimer R 0.5μl, cDNA 2ul, add water to a total volume of 10μl, and the above reaction system The PCR reaction was performed on a Realtime PCR (ViiA 7 Real-timePCR System, Applied Biosystems) instrument. The primers for each gene were designed as follows, the ex...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com